ASCO Genitourinary Cancers Symposium

 

ASCO Genitourinary Cancers Symposium
M

ASCO GU 2022 on the Immune Profiling of Advanced Prostate Cancer Harboring Homologous Recombination Deficiency

By ASCO Genitourinary Cancers Symposium FEATURING Maryam Soleimani
By ASCO Genitourinary Cancers Symposium FEATURING Maryam Soleimani
148 views
February 28, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Videos
08:55
ASCO Genitourinary Cancers Symposium

ASCO GU 2022: Community Oncologists’ Perceptions of and Barriers to …

Feat. A. Gajra
09:36
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on EV-103 Cohort H: Antitumor Activity of Neoadjuvant T…

Feat. N. Mar
08:54
ASCO Genitourinary Cancers Symposium

Trials in Progress in Neoadjuvant Systemic Therapy in MIBC

Feat. P. Grivas
11:23
ASCO Genitourinary Cancers Symposium

ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Pre…

Feat. D. Spratt
12:14
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up:…

Feat. S. Tykodi
06:52
ASCO Genitourinary Cancers Symposium

ASCO GU 2022: Tumor Mutational Burden as a Predictive Biomarker for …

Feat. S. Gupta
20:27
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Radiation Therapy in Localized Prostate Cancer: Chan…

Feat. A. Bossi
13:49
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Multi-Institutional Matched Comparison of Radical Cy…

Feat. A. Zlotta
09:54
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Updates on the Randomized Meet-URO12 Trial: Niraparib +…

Feat. M. Di Maio
04:06
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Updates on the Phase 3 TITAN Study: The Effect of Prior…

Feat. K. Chi
10:53
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 TROPHY-U-01 Cohort 3: Sacituzumab Govitecan + Pembroliz…

Feat. P. Grivas
05:41
Fred Saad

ARASENS Trial Updates: OS With Darolutamide vs. Placebo in Combinati…

11:45
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 PROpel Phase III Trial Highlights: Olaparib & Abira…

Feat. F. Saad
08:02
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Updates on the ARIES Trial: 1L Avelumab in PD-L1+ Meta…

Feat. R. Iacovelli
11:11
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoad…

Feat. D. Petrylak
07:47
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on a Phase II Study of Nivo + Ipi for Advanced GU Malig…

Feat. B. McGregor
11:32
ASCO Genitourinary Cancers Symposium

ASCO GU 2022: Phase II/III Clinical Results of IL-15RαFc Superagonis…

Feat. S. Chang
10:01
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Management of Toxicities With Novel Systemic Therapi…

Feat. T. Flaig
07:12
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Bone Mineral Density in De Novo mCSPC Treated With/W…

Feat. G. Roubaud
08:35
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on 1L Axitinib + Pembro in Advanced RCC: Real-World Tre…

Feat. Y. Zakharia
04:01
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Nivo + Cabo vs. Sunitinib for Advanced RCC: Final OS…

Feat. T. Powles
05:00
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 OS in mHSPC Treated With Enzalutamide + ADT by High/Low…

Feat. A. Armstrong
06:48
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 CABOSEQ Trial Updates on the Efficacy of Cabozantinib P…

Feat. V. Navani
08:33
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on the Immune Profiling of Advanced Prostate Cancer Har…

Feat. M. Soleimani
05:43
ASCO Genitourinary Cancers Symposium

ASCO GU 2022: A Phase I/II Study of Nivo & Axitinib in Patients …

Feat. M. Zibelman
06:49
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Gem & Cis as Neoadjuvant Chemo in High-Grade UTU…

Feat. W. Yip
16:00
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

Feat. M. Dean
07:40
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Futibatinib + Pembro in Advanced/Metastatic UC: Prel…

Feat. V. Koshkin
09:23
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Molecular Alterations Across Sites of Metastasis in …

Feat. R. McKay
07:53
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Updates on Neoadjuvant Cabozantinib in Locally Advanced…

Feat. M. Bilen
06:58
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on the Updated OS Analysis for Docetaxel +/- Capivasert…

Feat. S. Crabb
11:54
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Efficacy & Safety of Continuing Enza in Chemo-Naïve…

Feat. A. Merseburger
03:02
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Pembro as Post-Nephrectomy Adjuvant Therapy for RCC:…

Feat. T. Choueiri
07:45
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Cabozantinib in Advanced RCC After the Failure of CP…

Feat. V. Grünwald
13:17
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Highlights on the ADCs in Advanced Urothelial Cancer: C…

Feat. S. Tagawa
05:16
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Survival Outcomes and Characterization of Patients With…

Feat. N. Sayegh
16:34
ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oli…

Feat. N. Haas